Home > Financial Ratios > SEQUENT SCIENTIFIC

SEQUENT SCIENTIFIC
Core EBITDA Growth

    Back to All Ratios
SEQUENT SCIENTIFIC is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SEQUENT SCIENTIFIC
Please provide your vote to see the results

SEQUENT SCIENTIFIC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 294.50-84.74-45.4522.1835.03

What is the latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC ?

The latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC is 294.50 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024294.50
Mar2023-84.74
Mar2022-45.45
Mar202122.18
Mar202035.03

How is Core EBITDA Growth of SEQUENT SCIENTIFIC Trending?

Years Core EBITDA Growth % Change
Mar2024 294.5
Positive
Mar2023 -84.74
Negative
Mar2022 -45.45
Negative
Mar2021 22.18
-36.68
Mar2020 35.03 -

Other Financial Ratios of SEQUENT SCIENTIFIC


Compare Core EBITDA Growth ratio of peers of SEQUENT SCIENTIFIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC ₹3,485.4 Cr -2.7% -12% 14.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,548.0 Cr 5.6% 0.1% 9.5% Stock Analytics
DIVIS LABORATORIES ₹153,385.0 Cr 4.3% -3.9% 63.1% Stock Analytics
CIPLA ₹121,845.0 Cr 4.3% 2.5% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,123.0 Cr 2.5% 2% 14.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,189.0 Cr 4.3% -4.8% -8.7% Stock Analytics


SEQUENT SCIENTIFIC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC

-2.7%

-12%

14.7%

SENSEX

1.6%

-1.1%

2.2%


You may also like the below Video Courses